Ryzhuk, A.; Kovalenko, S.M.; Georgiyants, M.; Vysotska, K.; Georgiyants, V.
Monoclonal Antibodies as a Breakthrough in Personalised Leukaemia Therapy: What Pharmacists and Doctors Should Know. Pharmacy 2025, 13, 169.
https://doi.org/10.3390/pharmacy13060169
AMA Style
Ryzhuk A, Kovalenko SM, Georgiyants M, Vysotska K, Georgiyants V.
Monoclonal Antibodies as a Breakthrough in Personalised Leukaemia Therapy: What Pharmacists and Doctors Should Know. Pharmacy. 2025; 13(6):169.
https://doi.org/10.3390/pharmacy13060169
Chicago/Turabian Style
Ryzhuk, Anastasiia, Sergiy M. Kovalenko, Marine Georgiyants, Kateryna Vysotska, and Victoriya Georgiyants.
2025. "Monoclonal Antibodies as a Breakthrough in Personalised Leukaemia Therapy: What Pharmacists and Doctors Should Know" Pharmacy 13, no. 6: 169.
https://doi.org/10.3390/pharmacy13060169
APA Style
Ryzhuk, A., Kovalenko, S. M., Georgiyants, M., Vysotska, K., & Georgiyants, V.
(2025). Monoclonal Antibodies as a Breakthrough in Personalised Leukaemia Therapy: What Pharmacists and Doctors Should Know. Pharmacy, 13(6), 169.
https://doi.org/10.3390/pharmacy13060169